Literature DB >> 15234861

The changing face of the HIV epidemic in western Europe: what are the implications for public health policies?

Françoise F Hamers1, Angela M Downs.   

Abstract

In this review, we describe changes in dynamics of HIV transmission and shifts in affected populations in western Europe using HIV/AIDS surveillance data and published and unpublished reports. Despite substantial reductions in HIV-related morbidity and mortality since the introduction of highly active antiretroviral treatment, HIV continues to pose a major public health problem in western Europe. More than half a million people are living with an infection that remains incurable and requires costly lifelong treatment; many people remain unaware of their infection, and thousands of new infections continue to occur every year. Migrants from countries with a high prevalence of HIV/AIDS, notably sub-Saharan Africa, bear a disproportionate and increasing share of HIV throughout western Europe and, in most countries, account for the majority of heterosexually acquired HIV infections diagnosed in recent years. Prevention, treatment, and care must be adapted to reach migrant populations. Following a resurgence of risky sexual behaviour, HIV transmission may now be increasing among homosexual and bisexual men, and renewed safer sex campaigns are urgently needed.

Entities:  

Mesh:

Year:  2004        PMID: 15234861     DOI: 10.1016/S0140-6736(04)16594-X

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  38 in total

Review 1.  The impact of disease stage on direct medical costs of HIV management: a review of the international literature.

Authors:  Adrian Levy; Karissa Johnston; Lieven Annemans; Andrea Tramarin; Julio Montaner
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

2.  Cost effectiveness of darunavir/ritonavir 600/100 mg bid in protease inhibitor-experienced, HIV-1-infected adults in Belgium, Italy, Sweden and the UK.

Authors:  Karen Moeremans; Lieven Annemans; Mickael Löthgren; Gabriele Allegri; Veronique Wyffels; Lindsay Hemmet; Karin Caekelbergh; Erik Smets
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

Review 3.  Clinical management of treatment-experienced, HIV/AIDS patients in the combination antiretroviral therapy era.

Authors:  Mark A Boyd; Andrew M Hill
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

4.  Cost effectiveness of darunavir/ritonavir 600/100 mg bid in treatment-experienced, lopinavir-naive, protease inhibitor-resistant, HIV-infected adults in Belgium, Italy, Sweden and the UK.

Authors:  Karen Moeremans; Lindsay Hemmett; Jonas Hjelmgren; Gabriele Allegri; Erik Smets
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

5.  Trends in HIV testing, serial HIV prevalence and HIV incidence among people attending a Center for AIDS Prevention from 1988 to 2003.

Authors:  I Hurtado; I Alastrue; I Ferreros; J del Amo; C Santos; T Tasa; I Hernández-Aguado; S Pérez-Hoyos
Journal:  Sex Transm Infect       Date:  2006-06-06       Impact factor: 3.519

6.  Impact of immigration and HIV infection on tuberculosis incidence in an area of low tuberculosis prevalence.

Authors:  I Baussano; M Bugiani; D Gregori; C Pasqualini; V Demicheli; F Merletti
Journal:  Epidemiol Infect       Date:  2006-04-20       Impact factor: 2.451

7.  Refugees and family-reunified immigrants have a high incidence of HIV diagnosis and late presentation compared with Danish born: a nationwide register-based cohort study.

Authors:  Laura Deen; Susan Cowan; Christian Wejse; Jørgen Holm Petersen; Marie Norredam
Journal:  Infection       Date:  2018-07-03       Impact factor: 3.553

8.  Rate and incidence estimates of recent human immunodeficiency virus type 1 infections among pregnant women in Sao Paulo, Brazil, from 1991 to 2002.

Authors:  Carmem A de Freitas Oliveira; Mirthes Ueda; Rosemeire Yamashiro; Rosângela Rodrigues; Haynes W Sheppard; Luís Fernando de Macedo Brígido
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

9.  Disease severity, self-reported experience of workplace discrimination and employment loss during the course of chronic HIV disease: differences according to gender and education.

Authors:  R Dray-Spira; A Gueguen; F Lert
Journal:  Occup Environ Med       Date:  2007-11-02       Impact factor: 4.402

10.  Imported infectious diseases in mobile populations, Spain.

Authors:  Begoña Monge-Maillo; B Carolina Jiménez; José A Pérez-Molina; Francesca Norman; Miriam Navarro; Ana Pérez-Ayala; Juan M Herrero; Pilar Zamarrón; Rogelio López-Vélez
Journal:  Emerg Infect Dis       Date:  2009-11       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.